Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1963 1
1964 1
1965 1
1966 1
1969 1
1970 2
1971 2
1981 2
1982 1
1985 1
1986 5
1987 5
1988 6
1989 9
1990 3
1991 9
1992 17
1993 10
1994 7
1995 7
1996 12
1997 7
1998 13
1999 11
2000 8
2001 11
2002 13
2003 15
2004 25
2005 25
2006 30
2007 44
2008 50
2009 48
2010 52
2011 65
2012 61
2013 74
2014 93
2015 92
2016 97
2017 113
2018 119
2019 133
2020 153
2021 183
2022 161
2023 162
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

1,753 results

Results by year

Filters applied: . Clear all
Page 1
The NLR gene family: from discovery to present day.
Chou WC, Jha S, Linhoff MW, Ting JP. Chou WC, et al. Nat Rev Immunol. 2023 Oct;23(10):635-654. doi: 10.1038/s41577-023-00849-x. Epub 2023 Mar 27. Nat Rev Immunol. 2023. PMID: 36973360 Review.
AIM2 in regulatory T cells restrains autoimmune diseases.
Chou WC, Guo Z, Guo H, Chen L, Zhang G, Liang K, Xie L, Tan X, Gibson SA, Rampanelli E, Wang Y, Montgomery SA, Brickey WJ, Deng M, Freeman L, Zhang S, Su MA, Chen X, Wan YY, Ting JP. Chou WC, et al. Nature. 2021 Mar;591(7849):300-305. doi: 10.1038/s41586-021-03231-w. Epub 2021 Jan 27. Nature. 2021. PMID: 33505023 Free PMC article.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Wang ES, Montesinos P, Minden MD, Lee JH, Heuser M, Naoe T, Chou WC, Laribi K, Esteve J, Altman JK, Havelange V, Watson AM, Gambacorti-Passerini C, Patkowska E, Liu S, Wu R, Philipose N, Hill JE, Gill SC, Rich ES, Tiu RV. Wang ES, et al. Among authors: chou wc. Blood. 2022 Oct 27;140(17):1845-1857. doi: 10.1182/blood.2021014586. Blood. 2022. PMID: 35917453 Free PMC article. Clinical Trial.
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.
Worby CJ, Schreiber HL 4th, Straub TJ, van Dijk LR, Bronson RA, Olson BS, Pinkner JS, Obernuefemann CLP, Muñoz VL, Paharik AE, Azimzadeh PN, Walker BJ, Desjardins CA, Chou WC, Bergeron K, Chapman SB, Klim A, Manson AL, Hannan TJ, Hooton TM, Kau AL, Lai HH, Dodson KW, Hultgren SJ, Earl AM. Worby CJ, et al. Among authors: chou wc. Nat Microbiol. 2022 May;7(5):630-639. doi: 10.1038/s41564-022-01107-x. Epub 2022 May 2. Nat Microbiol. 2022. PMID: 35505248 Free PMC article.
Current Trends in Neoantigen-Based Cancer Vaccines.
Ho SY, Chang CM, Liao HN, Chou WH, Guo CL, Yen Y, Nakamura Y, Chang WC. Ho SY, et al. Among authors: chou wh. Pharmaceuticals (Basel). 2023 Mar 5;16(3):392. doi: 10.3390/ph16030392. Pharmaceuticals (Basel). 2023. PMID: 36986491 Free PMC article. Review.
Editorial Comment.
Chou WH, Chakiryan NH. Chou WH, et al. J Urol. 2024 Apr;211(4):572-573. doi: 10.1097/JU.0000000000003836.01. Epub 2024 Jan 19. J Urol. 2024. PMID: 38241207 No abstract available.
1,753 results